Navigation Links
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
Date:11/26/2007

NEW YORK, Nov. 26 /PRNewswire/ -- The worldwide burn treatment market experienced growth of 7.6% from 2001 to 2006, reaching $1.9 billion. Wound Care Markets, Volume II: Burns, a new report by Kalorama Information, projects that the market will experience a few ups and downs due to price constraints, new technologies, and additional market penetration, but will grow more than $700 million by 2011.

Conventional, mature products continue to generate the majority of sales. However, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. According to the report, the market should exhibit an overall steady growth rate due to the increasing availability of new therapeutic techniques that result in decreasing healing times and subsequent cost savings.

Revolutionary advances using tissue engineering, growth factors, animal- fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience any type of burn, and the numerous products currently in development appear to be the key to successful growth in this market.

"As the wound care markets mature, partnerships are becoming more prevalent as a means of staving off the status quo," notes Mary Anne Crandall, the report's author. "Competitors that offer traditional mature products must look for ways to incorporate advanced wound care products for treating burns into their existing products or to improve the existing products significantly to remain competitive with emerging technologies."

Wound Care Markets, Volume II: Burns focuses on total manufacturers' revenues from six product categories: anti-infectives, burn injury management, moist dressings, biological dressings, pressure relief, and miscellaneous treatments. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry. This report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Wound-Care-Edition-1399490. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information supplies the latest in independent market research on medical markets including biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.

Contact:

Tom Ehart

MarketResearch.com

240-747-3014

tehart@marketresearch.com


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Coherent, Inc. Receives Expected Letter from NASDAQ
2. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
3. Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
4. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
5. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
6. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
Breaking Biology Technology:
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):